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(~10–50 µm). Furthermore, the excellent resolution of OCT 
imaging makes it possible to visualise plaque characteristics 
only reported by histopathological studies in vivo [3]. 
Therefore, the aim of our review was to describe the 
current status of coronary intravascular OCT imaging with 
particular emphasis on acute MI patients. Has the prime 
time for routine OCT imaging to guide effectively primary 
PCI arrived yet?
DECISION-MAKING DURING PCI
Revascularisation strategy in patients with acute MI depends 
largely on the clinical presentation [4]. In ST-segment elevation 
MI (STEMI), the strategy is rather straightforward: reperfusion 
should be performed as early as possible, and primary PCI 
should be limited to the culprit vessel, with the exception of 
cardiogenic shock or persistent ischaemia. On the other hand, 
patients without ST-segment elevation MI (NSTEMI) represent 
a heterogeneous population. Those at (very) high risk should 
be considered for angiography within 2 to 24 h. The revas-
cularisation strategy should be based on the clinical status 
as well as the disease severity (distribution and angiographic 
lesion characteristics). 
Numerous potential advantages and clinical applica-
tions of the OCT during elective as well as urgent PCI may 
be relevant in decision-making during PCI: pre-procedural 
evaluation of target coronary lesions and planning of the 
revascularisation technique, peri-procedural guidance of the 
PCI itself, and post-procedural assessment of PCI-induced 
vascular injuries and their healing. Moreover, a lot of new 
exciting possibilities will keep our attention focused in the near 
future. In the setting of primary PCI, however, the OCT imag-
ing may be particularly helpful in the following four stages: (1) 
culprit lesion; (2) thrombus burden; (3) stent implantation; and 
(4) stent-related vascular injury and healing.
RATIONALE
The primary aim of percutaneous coronary 
intervention (PCI) is to obtain excellent 
results in all attempted lesions without any 
procedure-related complications. However, 
it is equally important to guarantee that the 
benefits of revascularisation are durable. 
Stent implantation in the acute myocardial 
infarction (MI) setting may allow various 
pathogenetic mechanisms to run aggres-
sively, thus leading to further ischaemic 
events [1]. Ruptured vulnerable plaques 
containing large necrotic cores combined 
with increased platelet reactivity can create 
a potent pro-thrombotic environment. Mas-
sive thrombotic leftovers despite vigorous 
thrombo-aspiration as well as epicardial 
vasoconstriction, which is only partly re-
sponsive to nitrates, altogether give way to 
substantial underestimation of the true vessel 
size and, consequently, to the implantation 
of undersized stents.
Intravascular imaging certainly holds 
great potential for the discovery of most of 
the unfavourable morphologic features. In-
deed, intravascular ultrasound studies (IVUS) 
have so far clearly demonstrated that stent 
under-expansion, alone or in combination with other PCI-re-
lated morphologies, contributed to the occurrence of stent 
thrombosis or restenosis [2]. Optical coherence tomography 
(OCT) is a light-based imaging modality using near-infrared 
wavelength (range ~1.3 µm). It shows superior axial resolution 
(~15 µm) compared with other intravascular systems cur-
rently used in vivo, such as IVUS (~150 µm) and angioscopy 
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ASSESSMENT OF CULPRIT LESION
OCT characteristics for different components of atheromatous 
plaque have been validated in histology-controlled studies and 
confirmed in patients with various clinical presentations [3]. 
With regard to tissue characterisation, OCT allows us to iden-
tify three types of coronary plaque: fibrous, fibro-calcific, and 
lipid plaques [5]. Furthermore, OCT can distinguish several 
essential unstable features such as thin-cap fibroatheromas 
(TCFA), plaque ruptures, erosions, thrombi, and calcified 
nodules. Pathohistological features of a vulnerable plaque 
include a large lipid pool and a thin fibrous cap infiltrated 
with macrophages [6]. In the OCT images, necrotic lipid pools 
appear as diffusely bordered, signal-poor regions with over-
lying signal-rich bands corresponding to fibrous caps. TCFA 
is characterised by a large necrotic core (i.e. lipid present 
in ≥ two quadrants in any of the images within the plaque) 
with a thin fibrous cap (< 65 µm). Fibrous cap rupture is dis-
tinguished by the presence of fibrous cap discontinuity and 
a cavity formation of the plaque, while fibrous cap erosion is 
identified by the loss of the endothelial lining with lacerations 
of the superficial layers. Thrombus is recognised as a globular 
mass protruding into the vessel lumen from the surface of the 
vessel wall. Red thrombus appears as a high-backscattering 
structure with dorsal, signal-free shadowing, whereas white 
thrombus presents itself as a signal-rich, low-backscattering 
structure [5]. 
Acute MI is typically initiated by the sudden rupture 
or erosion of the vulnerable plaque followed by the throm-
bus formation and vascular spasm, altogether resulting in 
a critical luminal compromise. However, distinct pathologi-
cal features and clinical presentations associated with the 
plaque ruptures, erosions, and calcified nodules suggest 
that they may be caused by different pathophysiologic 
mechanisms and, therefore, might deserve tailored treat-
ment. It has been suggested that culprit lesions with lipid 
plaques, thinner fibrous caps, plaque ruptures (> 70% of 
all underlying mechanisms), fibrin-rich thrombi, and tighter 
obstructions are more common in patients with STEMI [7], 
whereas culprit lesions with fibrous or lipid plaques, thicker 
fibrous caps, plaque erosions (> 60% of all underlying 
mechanisms), platelet-rich thrombi, and wider obstructions 
are more frequent in patients with NSTEMI [8]. The calci-
fied nodules are the least common aetiology for acute MI 
(~5% of all underlying mechanisms) and are more common 
in older patients [7]. A typical culprit lesion in the STEMI 
setting is shown in Figure 1.
OCT, performed as the pre-interventional imaging in 
acute MI patients, appears particularly useful: (a) when the 
culprit lesion is unclear (e.g. intermediate lesions), (b) in case 
of diagnostic uncertainties on coronary angiogram (e.g. hazi-
ness), and (c) to rule out significant atherosclerotic plaque 
encroachment when planning the “minimalist immediate 
mechanical intervention” [9].
ASSESSMENT OF THROMBUS BURDEN
Large thrombi have been reported as independent predictors 
of post-procedural ischaemic events in patients treated with 
primary PCI for STEMI [10]. Despite mechanically achieving 
patent culprit arteries, up to 30% of these patients do not attain 
adequate myocardial tissue perfusion [11]. The reperfusion 
failure has been attributed to the no-reflow phenomenon 
related to distal embolisation of athero-thrombotic mate-
rial, coronary vasoconstriction, and reperfusion injury. The 
complete removal of the culprit thrombus is carried out with 
the intention of avoiding, at least partly, the problem of inap-
propriate myocardial perfusion. The use of thrombectomy 
devices, particularly manual aspiration, has been shown to im-
prove significantly the epicardial blood flow, myocardial blush 
grade, myocardial perfusion, and to decrease post-procedural 
ischaemic events [12]. However, some recent OCT studies 
have cast some doubts on the efficacy of the thrombectomy 
devices. In the study by Onuma et al. [11], manual thrombus 
aspiration failed to increase the coronary flow area as well 
as the stent area. Furthermore, OCT guidance for thrombus 
removal has lately been tested in two studies including 100 MI 
patients. However, thrombus aspiration managed to remove 
only ~50% of the intravascular thrombus burden, regardless of 
the initial thrombus amount, with similar rates for STEMI and 
Figure 1. Culprit lesion in a 61-year-old man with an 
ST-segment elevation myocardial infarction; A. Angiography 
initially shows the mid-left anterior descending artery occlu-
sion (arrow); B. Optical coherence tomography imaging after 
thrombus aspiration reveals a large lipid pool at the 11 o’clock 
position (arrow); C. Cavity formation is clearly visible at the 
same position (arrow) in front of the tightest vessel narrowing; 
D. The aperture of the ruptured plaque (arrow) is wide open 
against the direction of coronary blood flow
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NSTEMI patients. Moreover, after stent deployment, OCT was 
always able to reveal some thrombotic masses despite the op-
timal angiographic result [13]. In another study, high-pressure 
dilatations performed even after extensive thrombo-aspiration 
led to an additional increase not only in stent but also in lu-
men areas. Fortunately, the measures of epicardial and tissue 
myocardial perfusion, as well as the clinical outcomes, were 
not detrimentally affected by such additional dilatations [14]. 
OCT has demonstrated excellent diagnostic potential to 
accurately detect intracoronary thrombi [7]. In the course of 
primary PCI, OCT can be performed initially in incomplete 
coronary blockages to assess the overall thrombus burden and 
to guide selection of the most appropriate revascularisation 
strategy. However, the imaging should ideally be repeated 
after several thrombo-aspiration passages to check the re-
sidual thrombotic leftovers (Figs. 2, 3). In case of considerable 
thrombotic masses, the aspiration should be continued or 
more effective devices engaged. 
ASSESSMENT OF STENT IMPLANTATION
It has already been mentioned that primary PCI is associated 
with significantly increased rates of post-procedural ischaemic 
events. Therefore, stent implantation should be optimal in 
the acute MI setting to possibly improve short- and long-term 
clinical outcomes. OCT is thought to assist stent implantation 
by (a) finding appropriate landing zones for stent placement, 
(b) providing accurate measurements of target vessel width 
and tapering, lesion severity (particularly in NSTEMI) and 
length, and (c) evaluating stent expansion, apposition, and 
assessing residual stenosis after stent deployment.
Geometrical miss (GM) is an important indicator of 
suboptimal stent deployment. It is usually divided into two 
types, namely the longitudinal GM (i.e. diseased/injured ves-
sel segment not fully covered by the stent) and the axial GM 
(i.e. balloon-artery size ratio < 0.9 or > 1.3). Mintz et al. 
[15] reported that only 6.8% of the angiographically normal 
reference segments were found to be truly normal on IVUS, 
while the average percentage of cross-sectional narrowing of 
the reference segments was ~50%. The recent STLLR trial 
(the Impact of Stent Deployment Techniques on Clinical Out-
comes of Patients Treated With the CYPHER Stent) showed 
that GM occurred frequently in everyday PCI practice: overall 
GM in 66.5%, longitudinal GM in 47.6%, and axial GM in 
35.2%. Most of the difference in outcomes was due to the 
longitudinal GM [16]. Legutko et al. [17] demonstrated using 
Figure 3. Unsuccessful thrombus aspiration in a 40-year-old  
man with ST-segment elevation myocardial infarction;  
A. Angiography initially shows the mid-right coronary artery 
thrombotic occlusion (arrow); B. Angiography after manual 
thrombus aspiration reveals two tight lesions with possibly 
small thrombotic amounts; C. Optical coherence tomography 
imaging after thromboaspiration demonstrates a tight lesion 
with a large rupture at the 5 o’clock position (arrow); D. Large 
thrombotic masses distally at the 7–11 o’clock position (arrow) 
indicate unsuccessful thrombus removal by means of manual 
thrombus aspiration
Figure 2. Successful thrombus aspiration in a 47-year-old gen-
tleman with ST-segment elevation myocardial infarction;  
A. Angiography initially shows mid-right coronary artery  
sub-total occlusion with a large adjacent thrombus (arrow);  
B. Angiography after manual thrombus aspiration reveals 
a tight lesion devoid of any thrombus; C. Optical coherence 
tomography imaging after thrombus aspiration concurren-
tly confirms a large fibro-lipid plaque; D. Small thrombotic 
residues at the 9 o’clock position (arrow) indicate successful 
thrombus removal by means of manual thrombus aspiration
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virtual histology IVUS that the implanted stents failed to fully 
cover TCFAs in 35% of NSTEMI patients and in 50% of STEMI 
patients [18]. Incomplete coverage of the lipid-core lesions in 
unstable patients was likely associated with an increased risk 
for no-reflow, post-procedural (re)MI, and plaque progression 
leading to edge restenosis [19]. To improve contemporary 
PCI practices, a stepwise approach targeting plaque burden 
at stent edges by means of OCT would be useful. A case of 
post-procedural no-reflow after the stent had been placed on 
a large lipid pool is shown in Figure 4.
Stent under-expansion is defined by (a) the in-stent 
minimal lumen area ≥ 90% of the average lumen area, and 
(b) ≥ 100% of lumen area of the reference segment with 
the lowest lumen area. Incomplete stent apposition occurs 
if there is a visible separation of a stent strut from the vessel 
wall (sum of strut thickness + abluminal polymer thickness). 
Finally, reference luminal narrowing is defined as a lumen 
area < 4.0 mm2 [20]. In a mixed population containing 41% 
of patients with stable coronary artery disease and 60% with 
acute coronary syndrome, Prati et al. [21] recognised stent 
under-expansion in 11.4% and incomplete stent apposition in 
29.7%. Significant reference lumen narrowing was, somewhat 
surprisingly, only reported in 2.8% [20]. A case of incomplete 
stent apposition in a patient with acute MI is shown in Figure 5. 
Figure 4. Inappropriate stent placement in a 47-year-old  
woman with ST-segment elevation myocardial infarction;  
A. Angiography initially shows the mid-right coronary artery 
sub-total occlusion with a large adjacent thrombus (arrow);  
B. Optical coherence tomography imaging after thrombus 
aspiration and stent implantation reveals mostly well apposed 
stent; C. At the proximal stent edge, however, a few malappo-
sed stent struts (yellow arrow) are placed on a large vulnerable 
plaque at the 5–9 o’clock position (white arrow); D. Vulnerab-
le plaque (white arrow) largely protrudes beyond stent margins; 
E. Angiography after post-dilatation of the malapposed stent 
struts uncovers a no-reflow phenomenon (arrow)
Figure 5. Insufficient stent apposition in a 70-year-old man 
with a non-ST-segment elevation myocardial infarction;  
A. Angiography initially shows the proximal left circumflex 
artery sub-total occlusion (arrow); B. A drug-eluting stent 
(3.0 × 23 mm) is deployed at 16 atmospheres; C. Angiography 
after stent implantation reveals an acceptable result without 
any significant residual stenosis; D. Optical coherence tomo-
graphy imaging demonstrates a substantial malapposition of 
the proximal stent struts at the 6–14 o’clock position (arrow); 
E. Stent struts are well apposed only in a short mid-stent seg-
ment; F. Distinct malapposition of stent struts is seen distally 
at the 3–12 o’clock position (arrow)
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ASSESSMENT OF STENT-RELATED  
VASCULAR INJURY AND HEALING
Primary PCI is the approved reperfusion therapy in STEMI 
as well as in high-risk non-STEMI patients and stenting is 
recommended over balloon angioplasty alone [4]. Yet the PCI 
itself is inevitably associated with an extensive vascular injury 
because the improvement in lumen dimensions is a result 
of vessel stretch, plaque compression, medial dissection, 
and embolisation of plaque constituents. Early after stent-
ing, fibrin, platelets, and acute inflammatory cells are nearly 
always observed in association with stent struts. However, 
the concept that stents provide a boundary that excludes the 
underlying plaque from the lumen is not supported by patho-
morphological studies because penetration of stent struts into 
a lipid core is quite common [1]. It is reasonable to expect 
that high-resolution imaging such as OCT will reveal a lot of 
intraluminal abnormalities in patients undergoing primary PCI. 
In the OCT studies, acute effects of stent implantation 
on the vessel wall have been described as tissue prolapse, 
intra-stent dissection, edge dissection, and intra-stent thrombi 
[20]. Tissue prolapse is a convex-shaped protrusion of tissue 
between adjacent stent struts toward the lumen, without 
disruption of the continuity of the luminal vessel surface. The 
distance from the arc connecting adjacent stent struts to the 
greatest extent protrusion should be > 50 µm. Intra-stent 
dissection is a disruption of the luminal surface in the stent 
segment. It can appear in two forms, as a linear rim of tissue 
with a clear separation from the vessel wall, plaque, or stent 
struts, or as an empty cavity behind the struts. Conversely, 
edge dissection is defined as the presence of a linear rim of 
tissue with a width of ≥ 200 µm and a clear separation from 
the vessel wall of plaque that is adjacent (< 5 mm) to a stent 
edge. Gonzalo et al. [22] investigated 73 consecutive patients, 
41 with stable coronary artery disease and 32 with acute 
coronary syndrome. They reported tissue prolapse in 97.5%, 
intra-stent dissection in 91.1%, and edge dissection in 21.4%. 
The rate of different features of vascular damage was similar 
in diverse clinical presentations although the tissue prolapse 
was found to be more extensive in unstable patients. Typical 
OCT features of stent-related vascular injuries in acute MI 
patients are shown in Figures 6–8.
Some of the post-procedural OCT findings appear 
disturbing at first glance, although they are angiographically 
invisible. They may trigger unnecessary additional interven-
tions. Therefore, further refinement of the decision-making 
process during PCI is warranted. In general, acute findings 
after stenting, such as edge dissections, tissue protrusions, and 
incomplete stent apposition, detectable only on OCT, tend 
to be smaller at the follow-up than those seen on both OCT 
and IVUS. Most of them will resolve completely. Likewise, 
serial OCT data strongly suggest that the rates of incomplete 
stent apposition spontaneously decrease through the filling 
of the stent-lumen gap with neointima, without any clinical 
Figure 6. Multiple optical coherence tomography abnormali-
ties in an 80-year-old woman with a non-ST-segment elevation 
myocardial infarction; A. Angiography initially shows proximal 
right coronary artery occlusion (arrow); B. Angiography after 
stent implantation shows a satisfactory result. Optical coheren-
ce tomography imaging, however, reveals numerous abnormal 
features, such as tissue prolapse (C, arrow), intra-stent dissec-
tion (D, arrow), and intraluminal thrombus (E, arrow)
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events at mid-term follow-up. Gutierrez-Chico et al. [23] 
investigated in more detail the relationship between various 
limits for incomplete stent apposition and whether or not it 
persisted throughout the 12-month follow-up. They realised 
that strut-lumen distances < 270 µm resolved in all cases 
and those < 400 µm resolved in 93% of cases, without any 
occurrence of ST.
Previous reports have suggested an association between 
angiographic as well as IVUS-detected edge dissections and 
early ST. These and other studies consistently showed that, 
in addition to edge dissections, other abnormal findings 
were concurrently present, most consistently a low minimal 
lumen diameter/area, poor stent expansion, and a reduced 
final epicardial flow (TIMI < 3). Although there is not yet 
sufficient data to indicate which angiographically silent edge 
dissections will lead to adverse events, and thus require ad-
www.kardiologiapolska.pl
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ditional intervention, it is thought-provoking that only major 
abnormalities, such as longitudinal extensions > 8 mm by 
IVUS and circumferential extensions > 3 mm by OCT, will 
be associated with an adverse long-term clinical course [24]. 
PROCEDURAL AND CLINICAL CONSEQUENCES 
OF OCT IMAGING
Despite the emerging use of OCT in everyday interventional 
practice, prospective randomised clinical trials testing the abil-
ity of OCT to guide elective or primary PCI have not been per-
formed so far. Nevertheless, CLI-OPCI study (the Centro per la 
Figure 7. Angiographically visible edge dissection in a 47-year-
-old man with ST-segment elevation myocardial infarction;  
A. Angiography after stent implantation shows dissection at 
the distal stent edge; B. Stent placement at the mid-right coro-
nary artery segment (arrow); C. Stent struts at the distal stent 
edge are acceptably well apposed; D. Large dissection beyond 
the distal stent edge is seen at the 6 o’clock position (arrow)
Figure 9. Vessel dissection resulting from over-aggressive dilata-
tion in a 63-year-old woman with a non-ST-segment elevation 
myocardial infarction; A. Tight proximal left circumflex artery 
stenosis in anteroposterior caudal view (arrow); B. Same lesion in 
left anterior oblique (LAO) caudal view (arrow); C. Implantation 
of bare metal stent (4.5 × 18 mm) at 18 atmospheres in LAO 
caudal view; D. Angiography after stent implantation in LAO 
caudal view shows a “waist” in the middle of the stent;  
E. Optical coherence tomography imaging after stent implanta-
tion reveals insufficient stent expansion with intraluminal tissue 
prolapse at the 2–7 o’clock (arrow) position; F. High-pressure 
post-dilatation with too large balloon resulted in a Type C dissec-
tion (arrow) that needed implantation of an additional stent
Figure 8. Angiographically silent edge dissection in a 40-year-
-old man with an ST-segment elevation myocardial infarction; 
A. Angiography after stent implantation does not reveal any 
major dissections; B. Stent positioning at the mid-right coro-
nary artery segment; C. Stent struts at the distal stent edge are 
well apposed; D. Large dissection beyond the distal stent edge 
is seen at the 3 o’clock (yellow arrow) and 9 o’clock (white 
arrow) positions
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Lotta contro l’Infarto-Optimisation of Percutaneous Coronary 
Intervention) analysed a total of 670 patients: 264 patients 
with stable angina, 197 patients with NSTEMI, and 209 pa-
tients with STEMI [21]. 335 patients underwent OCT-guided 
PCI (study group) and 335 patients were managed with 
angiographic guidance alone (control group). The following 
actions were recommended when OCT disclosed significant 
procedural issues defined by protocol: (1) edge dissection and 
reference lumen narrowing required the implantation of an 
additional stent at the edge of the previously implanted stent; 
(2) stent underexpansion required further dilation of the pre-
viously implanted stent with a non-compliant balloon of the 
same diameter at ≥ 18 atmospheres (atm) or with a semi-com-
pliant balloon having a diameter ≥ 0.25 mm larger than the 
previously used balloon at ≥ 14 atm; (3) incomplete stent ap-
position required further dilation of the previously implanted 
stent with a non-compliant or semi-compliant balloon having 
a diameter ≥ 0.25 mm larger than the previously used balloon 
at ≥ 14 atm; and finally (4) thrombus required further dilation 
of the previously implanted stent with a non-compliant or 
semi-compliant balloon of the same diameter at 8–14 atm 
for 60 s. Additional interventions according to the adverse 
intracoronary OCT findings were needed in as many as 34.7% 
of the patients. Specifically, further dilatation was performed 
in 22.1% of cases: in 14.0% to fix stent under-expansion and 
in 8.1% to reduce intra-stent thrombus. Additional stenting 
was performed in 12.6% of cases. 
Short-term outcomes were similar in the OCT and 
control groups: cardiac death occurred in 0.6% in the study 
group vs. 0.9% in the control group (p = 0.1), whereas MI 
occurred in 3.9% in the study group vs. 6.5% in the control 
group (p = 0.118). On the other hand, unadjusted analysis 
at mid-term follow-up showed that the OCT group had a sig-
nificantly lower one-year risk of cardiac death (1.2% vs. 4.5% 
in the control group, p = 0.010), cardiac death or MI (6.6% 
vs. 13.0% in the control group, p = 0.0006), and a compos-
ite of cardiac death, MI, or repeat revascularisation (9.6% 
vs. 14.8% in the control group, p = 0.044). OCT guidance 
was associated with a significantly lower risk of cardiac death 
or MI even at extensive multivariable analysis adjusting for 
baseline and procedural differences between the groups and 
at propensity-score adjusted analyses. Unfortunately, potential 
differences in clinical outcomes between stable and unstable 
patients were not reported.
FEASIBILITY, SAFETY, AND EFFICACY  
OF OCT IMAGING
Current European Society of Cardiology guidelines on 
myocardial revascularisation, for the first time, recommend 
OCT as a tool for assessment of mechanisms of stent failure 
(class II a, level C) and in selected patients to optimise stent 
implantation (class II b, level C) [4]. The feasibility and safety 
of the endovascular imaging in critically ill patients, however, 
depend on the mechanical characteristics of the imaging 
probes, the additional time required for the set-up and data 
acquisition, and the necessity to provisionally occlude the 
investigated vessel. Early commercially available OCT versions 
used time domain detection that required proximal occlu-
sion of the investigated coronary artery. Currently available 
systems, instead, utilise frequency domain detection and 
do not require vessel occlusion. New OCT probes are low 
profile (2.6 French), flexible, with hydrophilic coating, and 
the acquisition speed is at least ten times higher compared 
with IVUS. The examined artery is rendered free of blood 
by means of iso-osmolar X-ray contrast injected by power 
injector at rates 2 to 4 mL/s (total volume ~30 mL), whereas 
low molecular weight dextran is widely used. Automated 
20 to 40 mm/s pullback allows for imaging of a 54 to 75 mm 
coronary segment during a 3-s injection. New high-resolution 
systems also provide for three-dimensional reconstruction 
with a 360o panoramic view of the vessel. The radial access 
tolerates OCT imaging though a trend towards less optimal 
image quality and more artifacts have been observed. Particu-
lar care should be taken in patients with renal insufficiency, 
haemodynamic instability, severely impaired contractility, 
last remaining coronary vessel, and allergy to flush medium. 
The imaging may be less successful in vessels with extreme 
tortuosity, large vessels (> 4.5 mm), very small vessels 
(< 1.5 mm), and poor fitting guide catheter. The vessel situ-
ation can be significantly worsened with occlusive OCT or 
guiding catheter, and with extensive vessel dissections. To 
date, limited experience does not suggest an increased risk 
in thrombosed lesions. Imaging of the left stem and bifurca-
tions is undertaken within the limits of the penetration depth.
The old, occlusive time domain system sometimes caused 
ST-segment (re)elevations, although they were irreversible. On 
the other hand, imaging with the newer frequency domain 
system was not associated with any major complications 
because no cases of significant arterial spasm, dissection or 
life-threatening arrhythmias (i.e. requiring pharmacologic 
therapy, revascularisation, or cardioversion/defibrillation) were 
reported [21]. Furthermore, no significant differences in 
post-procedural renal function were found in the OCT group 
as compared with the control group. However, some level of 
common sense to interpret the imaging findings is advised 
because too much aggressiveness may cause unnecessary 
vessel damage (Fig. 9).
Cost–effectiveness studies for the OCT-guided primary 
PCI in acute MI have not been performed yet. However, 
some deductions can possibly be made from similar IVUS 
studies. Mueller et al. [25] found that in-hospital costs for pro-
cedural personnel, capital equipment, and disposable devices 
were evidently higher in the IVUS group compared with the 
angiographically guided controls. On the other hand, two-year 
major adverse event-free survival was significantly higher in the 
IVUS-guided group (80% vs. 69% in angiographically-guided 
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group, p < 0.040). The authors concluded that, when used 
in a provisional stenting strategy, routine IVUS imaging is 
cost–efficient half of the time. Considering the unrivalled high 
resolution of the OCT imaging combined with its ease of use, 
the prospect of OCT becoming an indispensable imaging tool 
even in high-risk acute MI patients is challenging.
CONCLUSIONS
OCT imaging with its high resolution and ease of use seems 
promising in decision making during primary PCI, including 
evaluating controversial culprit lesions, assessing throm-
bus removal, facilitating stent implantation, and surveying 
stent-related vascular injury. When thoroughly tested in 
properly designed and conducted clinical trials, the imaging 
will certainly become a standard companion in the setting 
of primary PCI in the acute MI setting and complex PCI. All 
being well, our combined endeavours will assist us to reduce 
the unacceptably frequent post-procedural ischaemic events 
after the primary PCI.
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